BrightGene Bio-Medical Technology Co., Ltd. (SHA:688166)
China flag China · Delayed Price · Currency is CNY
57.35
-0.87 (-1.49%)
At close: Apr 17, 2026

SHA:688166 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
24,23320,74012,74814,7869,53515,051
Market Cap Growth
42.10%62.70%-13.79%55.07%-36.65%-19.85%
Enterprise Value
25,99122,55814,39115,98310,60615,560
Last Close Price
57.3549.0630.1534.8522.3636.17
PE Ratio
444.52380.4467.3973.0339.7961.70
Forward PE
-28.0028.0028.0028.0043.06
PS Ratio
19.8016.959.9412.549.3714.30
PB Ratio
8.517.295.256.124.258.64
P/TBV Ratio
9.928.495.576.524.549.47
P/OCF Ratio
74.5263.7851.9175.9230.6385.48
EV/Sales Ratio
21.2418.4311.2213.5510.4314.79
EV/EBITDA Ratio
124.10115.6048.2858.1139.1354.92
EV/EBIT Ratio
-437.4971.6876.7545.8462.45
Debt / Equity Ratio
0.840.840.920.910.900.52
Debt / EBITDA Ratio
11.4311.437.167.717.173.10
Net Debt / Equity Ratio
0.500.500.610.480.350.32
Net Debt / EBITDA Ratio
7.357.354.934.212.921.99
Net Debt / FCF Ratio
-11.18-11.18-126.33-5.54-1.90-0.77
Asset Turnover
0.220.220.250.240.270.44
Inventory Turnover
1.691.691.581.741.632.33
Quick Ratio
1.021.021.061.491.921.23
Current Ratio
1.401.401.562.002.391.70
Return on Equity (ROE)
1.40%1.40%5.83%7.44%10.62%14.97%
Return on Assets (ROA)
0.59%0.59%2.46%2.69%3.79%6.49%
Return on Invested Capital (ROIC)
1.21%1.26%4.83%5.79%7.57%13.37%
Return on Capital Employed (ROCE)
1.10%1.10%4.90%5.10%6.00%10.40%
Earnings Yield
0.22%0.26%1.48%1.37%2.51%1.62%
FCF Yield
-0.53%-0.62%-0.09%-1.41%-4.36%-4.87%
Dividend Yield
0.03%0.03%0.32%0.27%0.51%0.33%
Payout Ratio
215.73%215.73%71.75%56.80%41.77%22.26%
Buyback Yield / Dilution
0.24%0.24%0.34%-2.10%-1.61%1.87%
Total Shareholder Return
0.27%0.28%0.66%-1.82%-1.10%2.21%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.